Literature DB >> 9761042

Factors affecting excitatory amino acid release following severe human head injury.

R Bullock1, A Zauner, J J Woodward, J Myseros, S C Choi, J D Ward, A Marmarou, H F Young.   

Abstract

OBJECT: Recent animal studies demonstrate that excitatory amino acids (EAAs) play a major role in neuronal damage after brain trauma and ischemia. However, the role of EAAs in patients who have suffered severe head injury is not understood. Excess quantities of glutamate in the extracellular space may lead to uncontrolled shifts of sodium, potassium, and calcium, disrupting ionic homeostasis, which may lead to severe cell swelling and cell death. The authors evaluated the role of EEAs in human traumatic brain injury.
METHODS: In 80 consecutive severely head injured patients, a microdialysis probe was placed into the gray matter along with a ventriculostomy catheter or an intracranial pressure (ICP) monitor for 4 days. Levels of EAAs and structural amino acids were analyzed using high-performance liquid chromatography. Multifactorial analysis of the amino acid pattern was performed and its correlations with clinical parameters and outcome were tested. The levels of EAAs were increased up to 50 times normal in 30% of the patients and were significantly correlated to levels of structural amino acids both in each patient and across the whole group (p < 0.01). Secondary ischemic brain injury and focal contusions were most strongly associated with high EAA levels (27+/-22 micromol/L). Sustained high ICP and poor outcome were significantly correlated to high levels of EAAs (glutamate > 20 micromol/L; p < 0.01).
CONCLUSIONS: The release of EAAs is closely linked to the release of structural amino acids and may thus reflect nonspecific development of membrane micropores, rather than presynaptic neuronal vesicular exocytosis. The magnitude of EAA release in patients with focal contusions and ischemic events may be sufficient to exacerbate neuronal damage, and these patients may be the best candidates for treatment with glutamate antagonists in the future.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9761042     DOI: 10.3171/jns.1998.89.4.0507

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  113 in total

1.  Extracellular glutamate and other metabolites in and around RG2 rat glioma: an intracerebral microdialysis study.

Authors:  P F Behrens; H Langemann; R Strohschein; J Draeger; J Hennig
Journal:  J Neurooncol       Date:  2000-03       Impact factor: 4.130

2.  Selective mGluR5 antagonists MPEP and SIB-1893 decrease NMDA or glutamate-mediated neuronal toxicity through actions that reflect NMDA receptor antagonism.

Authors:  D M O'Leary; V Movsesyan; S Vicini; A I Faden
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

3.  Neuroprotective effects by nimodipine treatment in the experimental global ischemic rat model : real time estimation of glutamate.

Authors:  Seok Keun Choi; Gi-Ja Lee; Samjin Choi; Youn Jung Kim; Hun-Kuk Park; Bong Jin Park
Journal:  J Korean Neurosurg Soc       Date:  2011-01-31

Review 4.  Neuromonitoring in neurological critical care.

Authors:  Ian F Dunn; Dilantha B Ellegala; Dong H Kim; Zachary N Litvack
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

5.  [Cerebral microdialysis in stroke].

Authors:  C Berger; C Dohmen; M H Maurer; R Graf; S Schwab
Journal:  Nervenarzt       Date:  2004-02       Impact factor: 1.214

6.  Experimental mild traumatic brain injury induces functional alteration of the developing hippocampus.

Authors:  Zhe Yu; Barclay Morrison
Journal:  J Neurophysiol       Date:  2009-11-18       Impact factor: 2.714

Review 7.  Application of advanced neuroimaging modalities in pediatric traumatic brain injury.

Authors:  Stephen Ashwal; Karen A Tong; Nirmalya Ghosh; Brenda Bartnik-Olson; Barbara A Holshouser
Journal:  J Child Neurol       Date:  2014-06-22       Impact factor: 1.987

Review 8.  Mitochondrial damage & lipid signaling in traumatic brain injury.

Authors:  Andrew M Lamade; Tamil S Anthonymuthu; Zachary E Hier; Yuan Gao; Valerian E Kagan; Hülya Bayır
Journal:  Exp Neurol       Date:  2020-04-11       Impact factor: 5.330

9.  Imaging of hypoxic-ischemic penumbra with (18)F-fluoromisonidazole PET/CT and measurement of related cerebral metabolism in aneurysmal subarachnoid hemorrhage.

Authors:  Asita S Sarrafzadeh; Alexandra Nagel; Marcus Czabanka; Timm Denecke; Peter Vajkoczy; Michail Plotkin
Journal:  J Cereb Blood Flow Metab       Date:  2009-09-23       Impact factor: 6.200

10.  D-cycloserine improves functional outcome after traumatic brain injury with wide therapeutic window.

Authors:  Amos Adeleye; Esther Shohami; Dean Nachman; Alexander Alexandrovich; Victoria Trembovler; Rami Yaka; Yigal Shoshan; Jasbeer Dhawan; Anat Biegon
Journal:  Eur J Pharmacol       Date:  2009-12-01       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.